Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: Triple negative breast cancer is a disease with limited treatment options and the poorest outcome across all breast cancer subtypes, thus the need for new effective therapies is high. We recently found that navitoclax displays synergistic anti-proliferative and apoptotic activities w...

Descripción completa

Detalles Bibliográficos
Autores principales: Marczyk, Michal, Patwardhan, Gauri A., Zhao, Jun, Qu, Rihao, Li, Xiaotong, Wali, Vikram B., Gupta, Abhishek K., Pillai, Manoj M., Kluger, Yuval, Yan, Qin, Hatzis, Christos, Pusztai, Lajos, Gunasekharan, Vignesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563413/
https://www.ncbi.nlm.nih.gov/pubmed/32911681
http://dx.doi.org/10.3390/cancers12092551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563413/
https://www.ncbi.nlm.nih.gov/pubmed/32911681
http://dx.doi.org/10.3390/cancers12092551

Ejemplares similares